JANA DAVIS: Open Payments
NPI 1932424397 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,515 in 163 payments from 24 companies in 2025. Trend: 2023 $2,200 · 2024 $1,321 · 2025 $2,515
Food & beverage: $2,515
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $399 |
| ABBVIE INC. | 49 | $349 |
| Corcept Therapeutics | 7 | $324 |
| Kowa Pharmaceuticals America, Inc. | 12 | $218 |
| Amgen Inc. | 17 | $202 |
| PFIZER INC. | 9 | $161 |
| Lilly USA, LLC | 14 | $150 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| Antares Pharma, Inc. | 3 | $60 |
Products named: Auvelity, Korlym, ZORYVE, QULIPTA, MOUNJARO, UBRELVY, NURTEC ODT, OTEZLA.
Industry payments across TX — which companies pay providers there.
